Synopsis:
We investigated the diagnosis capability and extent of Anti-RA 33 positivity and clinical characteristics in patients with RA. We highlight a strong negative correlation between Anti-RA 33 positivity and the quality of life. Anti-RA 33 antibodies may exert helpful effects determining prognosis in established RA patients though have poor diagnostic capability.